Liver transplantation provided an overall survival of 60% in a previous study (SECA-I). Risk factors for death were carcinoembryonic antigen (CEA) >80 μg/L, progressive disease on chemotherapy, size of largest lesion>5.5 cm, and less than 2 years from resection of the primary tumor to transplantation.

Patients with synchronous unresectable CRLM who were not suitable for arms A, B or C of the SEcondary CAncer (SECA) II study who had undergone radical resection of the primary tumour and received chemotherapy were included; they underwent liver transplantation with extended criteria donor grafts.

2015年12月3日 · 1992 Yamaha XJ600S Seca II. The initial 1992 price of $3,800 (10 grand in today’s money) was a lot less expensive than the $5,200 FZR600—which was a $500 drop from the FZR’s 1991 price of $5,700....

2020年10月14日 · The SECA-I study showed an estimated 5-year survival of 60% in a heterogenous patient population and guided the development of the first clinical selection criteria. In the sequel SECA-II trial, an estimated 5-year survival of 83% was obtained.

1992年11月1日 · Designed to be simple, durable, easy to maintain and aesthetically attractive, the 598cc Seca II engine was basically new-from-the-ground-up when the bike debuted last year, borrowing only minor...

2019年6月26日 · At the center of this particular Venn diagram is Yamaha’s Seca II, a bike whose modest specifications belie its versatility, and whose used price is such a bargain you almost can’t afford to not...

2018年8月4日 · Considered a contra-indication to transplantation until recently, unresectable colorectal liver metastases (CRLM) have gained interest since the publication of the SECA trial by the University of Oslo. It showed a 5-year overall survival of 60%, comparable to the one of standard transplant indication.

Patients with synchronous unresectable CRLM who were not suitable for arms A, B or C of the SEcondary CAncer (SECA) II study who had undergone radical resection of the primary tumour and received chemotherapy were included; they underwent liver transplantation with extended criteria donor grafts.

Down on power and acceleration to racier 600s, the Seca II is still an able performer; our testbike zipped through the quartermile in 13.14 seconds at 99.77 mph. Top speed is 112 mph. Thanks to...

2023年7月1日 · The SECA-II trial reinforced that overall survival for patients with unresectable CRLM is improved with liver transplant compared to standard chemotherapy. 4, 5 Several studies are currently underway to evaluate safety and best …